Titan Bioplastics Business Model
-
As a formulation technology company, we charge clients a royalty to license our material IP for exclusive or non-exclusive use.
-
Exclusive licenses can control markets, and include sub-license terms, along with minimum sales requirements attached to the license.
-
We sell compounded resin materials to our clients.
-
We sell masterbatch resins
-
We sell masterbatch Titan Nanofill loaded resin in either PE, PP, PET and PLA
-
Each formulation is only licensed to the specific market. This means formulations can alternatively be licensed to multiple segments of industry.
-
We credit any custom development fees back to the client with a licensing agreement.
WHY TITAN BIOPLASTICS?
-
Companies are being forced by consumer consensus to approach bio material options.
-
Lack of science expertise to adopt formulation for large scale manufacturing.
-
The use of nanotechnology in bio materials is a very select science.
-
Our integrated marketing is able to articulate & integrate the effective messaging.
-
8.3 billion tons of plastic made so far today.
-
6.3 billion tons have become trash
-
79% of that waste is currently sitting in landfills.
-
8 million tons of plastic ends up in the ocean every year.
-
By 2050 we will have 12 billion tons in landfill
-
Plastic production has doubled every 15 years and is currently outpacing every other man made material.
-
The US recycles less than 9% of its plastic every year.
-
It takes from 50 – 1,000 years for plastic to degrade.
-
Plastic chemicals can be absorbed by the body (93% of Americans age six and older test positive for BPA in their systems)